Family Medicine · Roseville, CA
NPI
1144308636
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1600 Eureka Rd
Roseville, CA, 95661
Phone (916) 784-4000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$168K
3,695 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Loi P Phan prescribed most often to Medicare patients was Atorvastatin Calcium, with 368 prescriptions and refills. In total Loi P Phan wrote 3,695 Medicare prescriptions that cost $168K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 368 | 1,214 | 138 | $4,509 |
| Lisinopril Generic | 166 | 531 | 63 | $2,019 |
| Amlodipine Besylate Generic | 135 | 438 | 49 | $1,682 |
| Levothyroxine Sodium Generic | 126 | 386 | 44 | $2,314 |
| Losartan Potassium Generic | 108 | 355 | 41 | $1,407 |
| Tamsulosin Hcl Generic | 94 | 289 | 31 | $1,605 |
| Fluticasone Propionate Generic | 89 | 110 | 37 | $1,815 |
| Metformin Hcl Er Metformin Hcl | 89 | 291 | 35 | $726 |
| Simvastatin Generic | 89 | 296 | 33 | $1,037 |
| Metoprolol Tartrate Generic | 83 | 264 | 32 | $843 |
| Terazosin Hcl Generic | 75 | 227 | 25 | $3,989 |
| Allopurinol Generic | 71 | 233 | 24 | $906 |
| Trazodone Hcl Generic | 70 | 132 | 22 | $814 |
| Zolpidem Tartrate Generic | 64 | 64 | 12 | $403 |
| Atenolol Generic | 64 | 202 | 26 | $707 |
Brand drugs: 298 claims; generic drugs: 3,366 claims; opioid claims: 90.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Loi P Phan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.